AT
Axsome Therapeutics Inc
🇺🇸XNAS.AXSMUnited StatesHealthcare
$211.25USDup +7.22 (+3.54%)OpenDelayed3:30 PM
Price$211.25+7.22 (+3.54%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US05464T1043
- CUSIP
- 05464T104
Company
- Employees
- 1,346
- Headquarters
- New York, United States
- Website
- https://www.axsome.com
- CEO
- Dr. Herriot Tabuteau M.D.
Market
- Shares outstanding
- 52.4M
- Market cap
- $11.07B
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $10.85B
- EPS LTM
- -$3.66calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -57.74calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $776.57M+56.87%up year on year
- Net income
- -$191.64M+22.38%up year on year
- Gross margin
- 93.24%+1.92%up year on year
- Free cash flow
- -$71.39M+40.93%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.